Protein and peptide microarrays, the emerging tools for proteomics and clinical assays, are high-throughput methods that track binding events and activities, and decide the function of proteins on a ...
In May, TheraCode acquired JPT Peptide Technologies, a wholly owned subsidiary of Jerini. JPT offers peptide-based products and services for vaccine development, immune monitoring, and peptide ...
Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Peptide Synthesis Company Evaluation Report" report has been added to ResearchAndMarkets.com's offering. The Peptide Synthesis Market Companies Quadrant ...
Peptides have emerged as indispensable tools in modern drug discovery, playing a central role in areas such as oncology, metabolic disorders, targeted delivery, and protein–protein interaction ...
There has been a recent revival in interest in peptide therapeutic development, with five of the top-selling drugs being peptides or proteins (Enbrel, Remicade, Humira, Avastin, MabThera) and many ...
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global peptide synthesis market is estimated to be valued at US$ 348.9 million in 2020 and is expected to exhibit a CAGR of 6.6% ...
Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Peptide Synthesis Market Size, Share & Trends Analysis Report By Product (Equipment, Reagents & Consumables), By Application (Therapeutics, Diagnosis), ...
BERLIN, April 22, 2020 (GLOBE NEWSWIRE) -- JPT Peptide Technologies (JPT) announces the launch of ready-to-use peptide tools to study and profile the immune response towards SARS-CoV-2 infection. The ...
Proteins sourced from microorganisms are attracting attention for their potential in biomanufacturing a variety of products, ...
What is it? As the name suggests, nonribosomal peptide synthesis (NRPS) generates polypeptides sans ribosome. The resultant peptides, generally short oligomers of two to perhaps 48 residues, are not ...
The global Peptide Synthesis Market is valued at USD 649.6 Million in 2024 and is projected to reach a value of USD 1660.1 Million by 2035 at a CAGR of 8.91% between 2025 and 2035. The Peptide ...